ヒト炭酸水素酸塩のイソフォーム選択的阻害のための戦略としてのステロイド性A/B環融合
Jiří Brynda1, Anita Kiss1, Klára Pospíšilová1
1Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences Prague Czech Republic kudova@uochb.cas.cz.
RSC advances
|February 20, 2026
まとめ
ステロイド化合物は,炭酸アンヒドラゼ (CA) 阻害剤として有望であり,特に癌に関連したCA IXを標的としています. エストラ-1,3,5(10) -トリエンやΔ5ステロイドのような特定の誘導体は,抗癌薬の開発の可能性を選択的に抑制します.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬用化学 薬用化学について
- 酵素学 酵素学とは
背景:
- 炭酸水素 (CAs) は,pH調節のための重要な金属酵素である.
- CA IXは低酸素腫瘍で過剰発現し,重要な抗癌標的となっています.
- ステロイドは,選択性酵素阻害剤を設計するための多用途の支架を提供します.
研究 の 目的:
- 炭酸アンヒドラゼイソフォームに対するステロイド化合物の抑制力を調査する.
- CA活性部位内のステロイド誘導体の結合モードを解明する.
- 癌に関連したCA IX.を標的とする有望なステロイド的支架を特定する.
主な方法:
- ステロイド硫黄酸塩誘導体の合成と評価.
- 選択された炭酸アンヒドラゼイソフォーム (CA II,CA IX) に対する抑制アッセイ.
- 酵素-阻害剤の相互作用と結合モードの構造分析.
主要な成果:
- ステロイドスルファメートは,活性部位である亜鉛イオンと効果的に連携します.
- エストラ-1,3,5(10) -トリエンの誘導体は,CA IIとCA IXのナノモラー阻害を示した.
- Δ5型ステロイド化合物は,CA IIよりもCA IXに対する選択性を示した.
- 結合相互作用は,CA IXのVal131のような,同型特異の活性部位残留物によって調節される.
結論:
- ステロイド化合物は,炭酸アンヒドラゼイソフォームの効果的な阻害剤である.
- エストラ-1,3,5(10) -トリエンおよびΔ5-ステロイド誘導体は,選択的なCA IX阻害の可能性を示しています.
- これらのステロイド的支架は,CA IXを標的とした抗がん薬の発見のためにさらなる開発を保証します.
関連する概念動画
Stereoisomerism of Cyclic Compounds
9.2K
In this lesson, we delve into the role of ring conformation and its stability, which determines the spatial arrangement and, consequently, the molecular symmetry and stereoisomerism of cyclic compounds. 1,2-Dimethylcyclohexane is used as a case study to evaluate the possible number of stereoisomers. Here, given the multiple (n = 2) chiral centers, there are 2n = 4 possible configurations that lack a plane of symmetry, as the ring skeleton exists in a non-planar chair conformation. In addition,...
9.2K
Regioselectivity and Stereochemistry of Hydroboration
7.8K
A significant aspect of hydroboration–oxidation is the regio- and stereochemical outcome of the reaction.
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn...
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn...
7.8K
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
5.0K
All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
5.0K
Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry
4.3K
Diels–Alder reactions between cyclic dienes locked in an s-cis configuration and dienophiles yield bridged bicyclic products.
4.3K
Adrenergic Receptors: ɑ Subtype
2.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K


